TG Therapeutics, Inc.TGTX
Recorded

TG Therapeutics, Inc. Canaccord Genuity's 46th Annual Growth Conference

Review the key takeaways and the transcript of this earnings call.

PeriodFY 0Duration26 minParticipants3

Transcript

Preview the first five paragraphs, organized by speaker.

Austin MoellerAerospace and Defense Technology Analyst

All right. Hi everybody. I'm Austin Moeller. I'm the Aerospace and Defense Technology Analyst here at Canaccord Genuity. Today, we are joined by Kevin Knopp and Joe Griffith from 908 Devices. We are going to talk about mass spectrometers and why they're so important for military and law enforcement. I guess just to start off, could you just give a brief overview of the company and talk about the company's transition from being a medical device business into the defense and public safety market?

Kevin KnoppPresident, CEO, and Co-Founder

Yeah, absolutely. Thanks so much for hosting us here today, Austin. Really appreciate the opportunity. Yeah. 908 Devices is creating a category of handheld detection solutions aimed at public safety and defense customers, really geared towards chemical detection and drug detection applications specifically. So the fentanyl crisis, nitazenes, xylazine, other compounds of the synthetic opioids, as well as toxic industrial chemicals, and having a complete suite of handheld devices to address those applications. From a medical device, as you put it, 908 really is coming back to our roots a little bit here. When we started the company in 2012, we built a handheld mass spec technology, which is taking a lab-grade technology of mass spec and taking it out of the lab and bringing it to the user that could have access at the point of need for immediate answers.

Kevin KnoppPresident, CEO, and Co-Founder

And the pinnacle of that to us was a battery-powered smallest that we could do at the time, and developing a solution that didn't exist, new category, and we did so with purpose-built for military and security applications. Now, you fast-forward, that mass spec is a platform, and we continue to look through applied areas and markets as well as into life sciences. When Austin's mentioning the medical devices, when we were at the throes of our IPO in 2020, we really were gearing up and launching products into the bioprocessing, biopharma space. About 15 months ago, we've divested that business line, and now we're fully focused on the category of defining handheld detection for these public health, safety, and defense markets.

Kevin KnoppPresident, CEO, and Co-Founder

In many ways, coming back to our roots, an area that we know well, and an area that we've seen a lot of strong growth over those years.

Austin MoellerAerospace and Defense Technology Analyst

How important is real-time chemical analysis for law enforcement, given the extremely long wait times to get results from laboratories?

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Explore more earnings calls.

View earnings calendar